MyFinsight
Home
Blog
About
Contact
Download
Download image
Net decrease in
cash, cash...
-$18,481K
Right-of-use assets
-$1,227K
Depreciation
$797K
Other current assets
-$608K
Prepaid expenses
-$309K
Impairment on lab equipment
held-for-sale
$271K
Share-based compensation
expense
$109K
Other liabilities
$2K
Cash flows used in
operating activities
-$18,481K
Canceled cashflow
$3,323K
Accounts payable and
accrued expenses
-$16,472K
Net loss
-$3,706K
Operating lease
liabilities
-$1,626K
Back
Back
Cash Flow
source: myfinsight.com
Mural Oncology plc (MURA)
Mural Oncology plc (MURA)